The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions - PubMed (original) (raw)
The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions
X Yu et al. J Virol. 1992 Aug.
Abstract
Accumulating evidence suggests that the matrix (MA) protein of retroviruses plays a key role in virus assembly by directing the intracellular transport and membrane association of the Gag polyprotein. In this report, we show that the MA protein of human immunodeficiency virus type 1 is also critical for the incorporation of viral Env proteins into mature virions. Several deletions introduced in the MA domain (p17) of human immunodeficiency virus type 1 Gag polyprotein did not greatly affect the synthesis and processing of the Gag polyprotein or the formation of virions. Analysis of the viral proteins revealed normal levels of Gag and Pol proteins in these mutant virions, but the Env proteins, gp120 and gp41, were hardly detectable in the mutant virions. Our data suggest that an interaction between the viral Env protein and the MA domain of the Gag polyprotein is required for the selective incorporation of Env proteins during virus assembly. Such an interaction appears to be very sensitive to conformational changes in the MA domain, as five small deletions in two separate regions of p17 equally inhibited viral Env protein incorporation. Mutant viruses were not infectious in T cells. When mutant and wild-type DNAs were cotransfected into T cells, the replication of wild-type virus was also hindered. These results suggest that the incorporation of viral Env protein is a critical step for replication of retroviruses and can be a target for the design of antiviral strategies.
Similar articles
- HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR, Novikova M, Alfadhli A, Hikichi Y, Kagiampakis I, KewalRamani VN, Barklis E, Freed EO. Tedbury PR, et al. J Virol. 2019 Dec 12;94(1):e01526-19. doi: 10.1128/JVI.01526-19. Print 2019 Dec 12. J Virol. 2019. PMID: 31619553 Free PMC article. - Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes.
Lee YM, Tang XB, Cimakasky LM, Hildreth JE, Yu XF. Lee YM, et al. J Virol. 1997 Feb;71(2):1443-52. doi: 10.1128/JVI.71.2.1443-1452.1997. J Virol. 1997. PMID: 8995670 Free PMC article. - Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.
Tedbury PR, Mercredi PY, Gaines CR, Summers MF, Freed EO. Tedbury PR, et al. J Mol Biol. 2015 Mar 27;427(6 Pt B):1413-1427. doi: 10.1016/j.jmb.2015.01.018. Epub 2015 Feb 7. J Mol Biol. 2015. PMID: 25659909 Free PMC article. - HIV-1 replication.
Freed EO. Freed EO. Somat Cell Mol Genet. 2001 Nov;26(1-6):13-33. doi: 10.1023/a:1021070512287. Somat Cell Mol Genet. 2001. PMID: 12465460 Review. - HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.
Checkley MA, Luttge BG, Freed EO. Checkley MA, et al. J Mol Biol. 2011 Jul 22;410(4):582-608. doi: 10.1016/j.jmb.2011.04.042. J Mol Biol. 2011. PMID: 21762802 Free PMC article. Review.
Cited by
- Probing Gag-Env dynamics at HIV-1 assembly sites using live-cell microscopy.
Muecksch F, Klaus S, Laketa V, Müller B, Kräusslich H-G. Muecksch F, et al. J Virol. 2024 Sep 17;98(9):e0064924. doi: 10.1128/jvi.00649-24. Epub 2024 Aug 13. J Virol. 2024. PMID: 39136462 Free PMC article. - Second site reversion of HIV-1 envelope protein baseplate mutations maps to the matrix protein.
Alfadhli A, Romanaggi C, Barklis RL, Barklis E. Alfadhli A, et al. J Virol. 2024 Feb 20;98(2):e0174223. doi: 10.1128/jvi.01742-23. Epub 2024 Jan 9. J Virol. 2024. PMID: 38193694 Free PMC article. - Interaction of TSG101 with the PTAP Motif in Distinct Locations of Gag Determines the Incorporation of HTLV-1 Env into the Retroviral Virion.
Maeda Y, Monde K, Terasawa H, Tanaka Y, Sawa T. Maeda Y, et al. Int J Mol Sci. 2023 Nov 20;24(22):16520. doi: 10.3390/ijms242216520. Int J Mol Sci. 2023. PMID: 38003710 Free PMC article. - Viral and Host Factors Regulating HIV-1 Envelope Protein Trafficking and Particle Incorporation.
Anokhin B, Spearman P. Anokhin B, et al. Viruses. 2022 Aug 5;14(8):1729. doi: 10.3390/v14081729. Viruses. 2022. PMID: 36016351 Free PMC article. Review. - The HIV-1 Gag Protein Displays Extensive Functional and Structural Roles in Virus Replication and Infectivity.
Marie V, Gordon ML. Marie V, et al. Int J Mol Sci. 2022 Jul 8;23(14):7569. doi: 10.3390/ijms23147569. Int J Mol Sci. 2022. PMID: 35886917 Free PMC article. Review.
References
- J Virol. 1984 Mar;49(3):918-24 - PubMed
- J Mol Biol. 1984 Apr 5;174(2):297-317 - PubMed
- J Mol Biol. 1979 Jul 15;131(4):819-37 - PubMed
- Virology. 1971 Aug;45(2):401-10 - PubMed
- Cell. 1990 Oct 5;63(1):77-86 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources